1-amino-2-hydroxynaphthalene-4-sulfonic acid, min. 90%, pa, ACS, 100 g, glass packaging

5-Bromo-benzo[2,1,3]thiadiazole, 95.0%, 1g

Buffer solution pH 9.00 0.02 (20 °C), 500 ml, ready-to-use buffer solution

1-(tert-butoxycarbonyl)-2-methyl-D-proline, 95.0%, 100g

(3R)-1-Benzyl-3-piperidinyl methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate hydrochloride (1:1), 98%, 1g

Sodium 4-(bromomethyl)benzenesulfonate, 95.0%, 250mg

N-Hydroxy-2-methyl-5-phenyl-furan-3-carboxamidine; hydrochloride, 95.0%, 1g

4-((2-AMINOETHYL)AMINO)-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE, 95%, 250mg

[2-(1H-imidazol-2-yl)ethyl]amine dihydrochloride, 97.0%, 2.5g

2-Methylimidazo[1,2-a]pyridine-7-carboxylic acid hydrochloride, 95%, 5g

Boc-Glycine ethyl ester, 95.0%, 1g

tert-Butyl (6-aminospiro[3.3]heptan-2-yl)carbamate, 95.0%, 250mg

Ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate, 95.0%, 10g